Aclaris Therapeutics, Inc.
ACRS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $25,256 | $25,402 | $30,357 | $24,570 |
| Short-Term Investments | $70,656 | $74,404 | $74,957 | $89,024 |
| Receivables | $4,680 | $194 | $250 | $318 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $4,202 | $3,226 | $12,039 |
| Total Curr. Assets | $100,592 | $104,202 | $108,790 | $125,951 |
| Property Plant & Equip (Net) | $3,239 | $868 | $942 | $1,008 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $71,297 | $81,084 | $85,211 | $90,302 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $406 | $2,993 | $3,151 | $3,066 |
| Total NC Assets | $74,942 | $84,945 | $89,304 | $94,376 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $175,534 | $189,147 | $198,094 | $220,327 |
| Liabilities | – | – | – | – |
| Payables | $9,187 | $8,797 | $6,354 | $4,690 |
| Short-Term Debt | $533 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $6,297 | $3,914 | $3,888 | $3,890 |
| Other Curr. Liab. | $5,858 | $10,873 | $7,527 | $11,589 |
| Total Curr. Liab. | $25,631 | $26,839 | $21,514 | $31,596 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $18,218 | $19,206 | $20,038 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $28,092 | $12,351 | $13,308 | $13,139 |
| Total NC Liab. | $29,803 | $30,569 | $32,514 | $33,177 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $55,434 | $57,408 | $54,028 | $64,773 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | -$947,989 | -$933,375 | -$917,946 | -$902,861 |
| AOCI | $597 | $482 | $434 | $97 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $120,100 | $131,739 | $144,066 | $155,554 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $175,534 | $189,147 | $198,094 | $220,327 |
| Net Debt | -$24,723 | -$25,402 | -$30,357 | -$24,570 |